Literature DB >> 17174068

A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Brian J Piper1.   

Abstract

The entactogen +/-3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug among college, high school, and, occasionally, middle school students. Preclinical research examining the acute and long-term effects of MDMA has predominately been conducted in reproductively mature subjects but there has been increasing interest in adolescent and in utero exposure. This review examines the acute and long-term responses to MDMA during perinatal, adolescent, and adult periods. The ability of MDMA to alter core body temperature emerges gradually during ontogeny while a reduction in body weight is evident at all ages. Learning and working-memory are also altered independent of the developmental stage of exposure. Current evidence suggests adults are more sensitive to the long-term serotonin depletions following MDMA but younger ages also exhibit substantial and rapid neuroplasticity. Sexually dimorphic MDMA responses have been identified for the acute hyperthermic and motoric effects of MDMA with pubescent males being especially susceptible. Several physiological, behavioral, and neurochemical MDMA issues requiring further study are also outlined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174068      PMCID: PMC1896315          DOI: 10.1016/j.ntt.2006.10.002

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  167 in total

1.  Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence.

Authors:  Miles Gregory Cunningham; Sujoy Bhattacharyya; Francine Mary Benes
Journal:  J Comp Neurol       Date:  2002-11-11       Impact factor: 3.215

2.  Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.

Authors:  Paul A T Kelly; Isobel M Ritchie; Linda Quate; Douglas E McBean; Henry J Olverman
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000.

Authors:  K W Simonsen; E Kaa; E Nielsen; D Rollmann
Journal:  Forensic Sci Int       Date:  2003-01-28       Impact factor: 2.395

4.  Mental disorders in ecstasy users: a prospective-longitudinal investigation.

Authors:  Roselind Lieb; Christian G Schuetz; Hildegard Pfister; Kirsten von Sydow; Hans Wittchen
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

5.  Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.

Authors:  E J Bull; P H Hutson; K C F Fone
Journal:  Neuropharmacology       Date:  2003-03       Impact factor: 5.250

6.  Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress.

Authors:  Michael T Williams; LaRonda L Morford; Sandra L Wood; Stephanie L Rock; Anne E McCrea; Masao Fukumura; Tanya L Wallace; Harry W Broening; Mary S Moran; Charles V Vorhees
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

7.  Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence.

Authors:  Sara Morley-Fletcher; Mauro Bianchi; Gilberto Gerra; Giovanni Laviola
Journal:  Eur J Pharmacol       Date:  2002-07-12       Impact factor: 4.432

8.  Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.

Authors:  Jerrold S Meyer; Syed F Ali
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 9.  Acute psychological and neurophysiological effects of MDMA in humans.

Authors:  Franz X Vollenweider; Matthias E Liechti; Alex Gamma; George Greer; Mark Geyer
Journal:  J Psychoactive Drugs       Date:  2002 Apr-Jun

Review 10.  MDMA: a review of epidemiologic data.

Authors:  Mim J Landry
Journal:  J Psychoactive Drugs       Date:  2002 Apr-Jun
View more
  13 in total

Review 1.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

2.  Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Authors:  Brittney M Cox; Mrudang M Shah; Teri Cichon; Manuel E Tancer; Matthew P Galloway; David M Thomas; Shane A Perrine
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-10       Impact factor: 5.067

3.  Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.

Authors:  Lynn T Singer; Derek G Moore; Sarah Fulton; Julia Goodwin; John J D Turner; Meeyoung O Min; Andrew C Parrott
Journal:  Neurotoxicol Teratol       Date:  2012-03-03       Impact factor: 3.763

4.  Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.

Authors:  Dominik K Biezonski; Brian J Piper; Nina M Shinday; Peter J Kim; Syed F Ali; Jerrold S Meyer
Journal:  Eur J Pharmacol       Date:  2012-12-28       Impact factor: 4.432

Review 5.  Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models.

Authors:  Eva M Marco; Simone Macrì; Giovanni Laviola
Journal:  Neurotox Res       Date:  2010-07-07       Impact factor: 3.911

6.  In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings.

Authors:  Derek G Moore; John J D Turner; Julia E Goodwin; Sarah E Fulton; Lynn T Singer; Andrew C Parrott
Journal:  Clin Dev Med       Date:  2011-02

7.  During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Authors:  Derek G Moore; John D Turner; Andrew C Parrott; Julia E Goodwin; Sarah E Fulton; Meeyoung O Min; Helen C Fox; Fleur M B Braddick; Emma L Axelsson; Stephanie Lynch; Helena Ribeiro; Caroline J Frostick; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

8.  Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats.

Authors:  Ana Belen Lopez-Rodriguez; Alvaro Llorente-Berzal; Luis M Garcia-Segura; Maria-Paz Viveros
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

9.  Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Hum Psychopharmacol       Date:  2015-07       Impact factor: 1.672

Review 10.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.